NO964672L - Nye tetracykliske 1,4-oksazinforbindelser, fremgangsmåter ved deres fremstilling og farmasöytiske sammensetninger innholdende dem - Google Patents

Nye tetracykliske 1,4-oksazinforbindelser, fremgangsmåter ved deres fremstilling og farmasöytiske sammensetninger innholdende dem

Info

Publication number
NO964672L
NO964672L NO964672A NO964672A NO964672L NO 964672 L NO964672 L NO 964672L NO 964672 A NO964672 A NO 964672A NO 964672 A NO964672 A NO 964672A NO 964672 L NO964672 L NO 964672L
Authority
NO
Norway
Prior art keywords
preparation
methods
pharmaceutical compositions
compositions containing
oxazine compounds
Prior art date
Application number
NO964672A
Other languages
English (en)
Other versions
NO308132B1 (no
NO964672D0 (no
Inventor
Jean-Louis Peglion
Bertrand Goument
Jean-Christophe Harmange
Mark Millan
Valerie Audinot
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of NO964672D0 publication Critical patent/NO964672D0/no
Publication of NO964672L publication Critical patent/NO964672L/no
Publication of NO308132B1 publication Critical patent/NO308132B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO964672A 1995-11-09 1996-11-05 Nye tetracykliske 1,4-oksazinforbindelser og farmasøytiske sammensetninger innholdende dem NO308132B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9513270A FR2741074B1 (fr) 1995-11-09 1995-11-09 Nouveaux composes tetracycliques de la 1,4-oxazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (3)

Publication Number Publication Date
NO964672D0 NO964672D0 (no) 1996-11-05
NO964672L true NO964672L (no) 1997-05-12
NO308132B1 NO308132B1 (no) 2000-07-31

Family

ID=9484393

Family Applications (1)

Application Number Title Priority Date Filing Date
NO964672A NO308132B1 (no) 1995-11-09 1996-11-05 Nye tetracykliske 1,4-oksazinforbindelser og farmasøytiske sammensetninger innholdende dem

Country Status (15)

Country Link
US (1) US5733908A (no)
EP (1) EP0773223B1 (no)
JP (1) JPH09169770A (no)
CN (1) CN1059443C (no)
AT (1) ATE198752T1 (no)
AU (1) AU709192B2 (no)
CA (1) CA2189731C (no)
DE (1) DE69611594T2 (no)
ES (1) ES2155585T3 (no)
FR (1) FR2741074B1 (no)
GR (1) GR3035432T3 (no)
NO (1) NO308132B1 (no)
NZ (1) NZ299725A (no)
PT (1) PT773223E (no)
ZA (1) ZA969412B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9810876D0 (en) 1998-05-20 1998-07-22 Smithkline Beecham Plc Compounds
MA26696A1 (fr) 1998-10-08 2004-12-20 Smithkline Beecham Plc Derives de tetrahydrobenzazepine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
CA2522666A1 (en) * 2003-04-18 2004-10-28 Pharmacia & Upjohn Company Llc Combination therapies for chronic obstructive pulmonary disease (copd)
FR2906249B1 (fr) 2006-09-26 2008-12-19 Servier Lab Composes tetracycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE64735T1 (de) 1984-05-10 1991-07-15 Ciba Geigy Ag Benzo-(pyrano und thiopyrano)-pyridine.
US4792548A (en) * 1986-05-21 1988-12-20 Warner-Lambert Company Trans-benzopyran-(4,3-b)-1,4-oxazine derivatives, intermediates and pharmaceutical use
WO1993024471A1 (en) 1992-06-02 1993-12-09 Whitby Research, Inc. Substituted naphthoxazines useful as dopaminergics
EP0697894A4 (en) * 1993-03-31 1996-05-01 Univ Pennsylvania DOPAMINE D-3 AND SEROTONIN (5-HT 1A) RECEPTOR LIGANDS AND IMAGING AGENTS
FR2721027B1 (fr) * 1994-06-08 1996-07-19 Adir Nouveaux dérivés tétracycliques de la 1,4-oxazine, leur procédé de préparation et les compositions pharmaceutiques les contenant.

Also Published As

Publication number Publication date
NO308132B1 (no) 2000-07-31
FR2741074B1 (fr) 1997-12-19
GR3035432T3 (en) 2001-05-31
AU7170496A (en) 1997-05-15
CA2189731C (fr) 2002-04-09
CN1156147A (zh) 1997-08-06
US5733908A (en) 1998-03-31
NO964672D0 (no) 1996-11-05
ES2155585T3 (es) 2001-05-16
EP0773223A1 (fr) 1997-05-14
EP0773223B1 (fr) 2001-01-17
CA2189731A1 (fr) 1997-05-10
ATE198752T1 (de) 2001-02-15
PT773223E (pt) 2001-06-29
DE69611594T2 (de) 2001-08-09
JPH09169770A (ja) 1997-06-30
DE69611594D1 (de) 2001-02-22
NZ299725A (en) 1997-11-24
FR2741074A1 (fr) 1997-05-16
CN1059443C (zh) 2000-12-13
AU709192B2 (en) 1999-08-26
ZA969412B (en) 1997-06-02

Similar Documents

Publication Publication Date Title
FR2654104B1 (fr) Nouveaux derives du 1,2-benzisoxazole, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
NO972510D0 (no) Nye benzisoksazol-forbindelser, fremgangsmåter ved deres fremstilling og farmasöytiske sammensetninger inneholdede dem
NO20001402L (no) Substituerte kromanderivater
NO950936L (no) 5-vinyl- og 5-etinylchinolon- og naftyridonkarboksylsyrer
NO964672D0 (no) Nye tetracykliske 1,4-oksazinforbindelser, fremgangsmåter ved deres fremstilling og farmasöytiske sammensetninger innholdende dem
AR021826A1 (es) COMPUESTOS DE 2- FENILPIRAN-4-ONA, PROCESOS PARA PREPARARLOS, USO DE UN COMPUESTO INTERMEDIARIO EN DICHOS, COMPOSICIoN FARMACÉUTICA QUE LOS COMPRENDE Y USO DE DICHOS COMPUESTOS Y DICHA COMPOSICIoN PARA LA FABRICACIoN DE UN MEDICAMENTO
DK0899267T3 (da) Disubstituerede trans-3,4,4a,5,6,10b-hexahydro-2H-napht[1,2-b]-1,4-oxiner, fremgangsmåde til fremstilling deraf og farmaceutiske sammensætninger indeholdende disse
KR960014107A (ko) 피리미디닐 아크릴산 유도체
FI952802A (fi) Uudet tetrasykliset piperidiini- ja 1,4-oksatsiiniyhdisteet, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
ES8401056A1 (es) "procedimiento para la fabricacion de derivados de la quinolina".
MX9200991A (es) Compuestos heterociclicos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
ES468532A1 (es) Un procedimiento para preparar un compuesto de sulfonio re- gulador del crecimiento de las plantas
NO976101D0 (no) Nye ellipticinforbindelser, en fremgangsmåte ved deres fremstilling, samt farmasöytiske blandinger som inneholder dem